Workflow
SHENZHEN FUHENG NEW MATERIALS CO.(832469)
icon
Search documents
富恒新材:续聘2024年度会计师事务所公告
2024-04-26 14:14
拟聘任的会计师事务所:中审众环会计师事务所(特殊普通合伙) 服务及收费情况:中审众环会计师事务所(特殊普通合伙)已为公司提供 5 年审 计服务,上期审计收费 65 万元,本期审计收费未确定 证券代码:832469 证券简称:富恒新材 公告编号:2024-022 深圳市富恒新材料股份有限公司拟续聘 2024 年度会计师事务所公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 涉及会计师事务所提供的资料、信息,会计师事务所保证其提供、报送或披 露的资料、信息真实、准确、完整,不得有虚假记载、误导性陈述或者重大遗漏。 重要内容提示: 一、拟续聘会计师事务所的基本情况 (一)机构信息 公司拟聘任中审众环会计师事务所(特殊普通合伙)为 2024 年年度的审计 机构。 1.基本信息 会计师事务所名称:中审众环会计师事务所(特殊普通合伙) 成立日期:2013 年 11 月 16 日 组织形式:特殊普通合伙 注册地址:湖北省武汉市武昌区中北路 166 号长江产业大厦 17-18 层 首席合伙人:石文先 2023 年度 ...
富恒新材:海通证券股份有限公司关于深圳市富恒新材料股份有限公司募投项目延期的核查意见
2024-04-26 14:14
海通证券股份有限公司关于深圳市富恒新材料股份有限公司 募集资金投资项目延期的核查意见 海通证券股份有限公司(以下简称"海通证券"或"保荐机构")作为深圳 市富恒新材料股份有限公司(以下简称"富恒新材"或"公司")向不特定合格 投资者公开发行股票并在北京证券交易所上市的持续督导保荐机构,根据《证券 发行上市保荐业务管理办法》《北京证券交易所股票上市规则(试行)》《北京证 券交易所证券发行上市保荐业务管理细则》等有关规定,对募集资金投资项目延 期进行了核查,具体情况如下: 一、募集资金基本情况 富恒新材向不特定合格投资者公开发行股票并在北京证券交易所上市的申 请于2023年6月20日经北京证券交易所上市委员会审议通过,并于2023年8月21日 获中国证券监督管理委员会同意注册(证监许可〔2023〕1860号)。 富恒新材获准向不特定合格投资者公开发行股票2,280万股(不含行使超额 配售选择权所发股份),超额配售新增发行股票数量342万股,每股发行价格为人 民币5.68元,本次募集资金总额为人民币148,929,600元,扣除各项发行费用人民 币22,732,605.28元,实际募集资金净额为人民币126,196 ...
富恒新材:董事会审计委员会履职情况报告
2024-04-26 14:14
证券代码:832469 证券简称:富恒新材 公告编号:2024-033 深圳市富恒新材料股份有限公司 二、会议召开情况 2023 年度,公司董事会审计委员会共召开 6 次会议,具体情况如下: 1、2023 年 3 月 3 日,公司召开第四届董事会审计委员会 2023 年第一次会议, 应到委员 3 名,实到委员 3 名,审议通过《2022 年度审计报告》、《关于 2022 年度 利润分配方案的议案》、《2022 年年度报告及摘要》、《关于续聘 2023 年度审计机构 的议案》、《关于公司内部控制鉴证报告的议案》和《关于公司非经常性损益的专 项审核报告的议案》。 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司治理 准则》及深圳市富恒新材料股份有限公司(以下简称"公司")《公司章程》、《董 事会审计委员会工作细则》等规定和要求,董事会审计委员会委员在 2023 年度任 期内勤勉尽责,积极开展工作,认真履行职责。现将 2023 年度的履职情况汇报如 下: 一、审计委员会基本情况 公司第四届董事会审计委员会由 2 名不在公司担任高级管理人员的独立董事 及在公司任职的 1 名董事组成,目前在任的分别为 ...
富恒新材(832469) - 2023 Q4 - 年度财报
2024-04-26 14:14
Company Overview - The company was selected as one of the fifth batch of "specialized, refined, distinctive, and innovative" small giant enterprises in July 2023[6]. - The company successfully went public on the Beijing Stock Exchange on September 18, 2023[6]. - The total share capital of the company is 108,420,000 shares[21]. - The company’s legal representative is Yao Xiuzhu[17]. - The company’s registered capital is RMB 108,420,000[22]. - The company operates in the manufacturing industry, specifically in the rubber and plastic products sector[20]. - The company is engaged in the research, production, sales, and service of modified plastics[21]. - The company is under the continuous supervision of Haitong Securities Co., Ltd. from September 18, 2023, to December 31, 2026[23]. - The company’s contact information includes a phone number: 0755-29726655 and an email: fuheng@szfh.com[18]. Financial Performance - The company's operating revenue for 2023 reached ¥579,614,366.49, representing a year-over-year increase of 23.96% compared to ¥467,592,744.33 in 2022[27]. - The net profit attributable to shareholders for 2023 was ¥57,675,295.87, marking a 26.26% increase from ¥45,678,059.07 in 2022[27]. - The gross profit margin improved to 19.58% in 2023, up from 19.33% in 2022[27]. - Total assets increased by 32.17% to ¥993,124,885.98 at the end of 2023, compared to ¥751,374,883.91 at the end of 2022[29]. - The net assets attributable to shareholders rose by 66.98% to ¥458,438,990.29 in 2023, up from ¥274,539,949.19 in 2022[29]. - The company's basic earnings per share increased by 16.07% to ¥0.65 in 2023, compared to ¥0.56 in 2022[30]. - The operating cash flow for 2023 was negative at -¥155,682,469.28, a significant decline of 623.91% from ¥29,715,585.20 in 2022[29]. - The company reported a total of ¥10,369,882.37 in non-recurring gains and losses for 2023, compared to ¥3,591,641.92 in 2022[34]. Operational Strategy - The company plans to continue optimizing its supplier management and procurement processes to enhance operational efficiency[37]. - The production model remains focused on customization, with production plans based on customer orders to meet specific material requirements[37]. - The company has established a stable customer base over 30 years, leveraging existing relationships to explore new cooperation opportunities[39]. - The R&D department focuses on developing new products based on market demand and customer feedback, ensuring rapid response to personalized needs[39]. Market Trends - The modified plastics market in China grew from 225 billion yuan in 2018 to 360.2 billion yuan in 2021, with a compound annual growth rate of 16.98%[46]. - China's modified plastics production increased from 15.63 million tons in 2016 to 26.5 million tons in 2021, with a compound annual growth rate of 11.14%[45]. - The demand for modified plastics is expected to rise due to the upgrading of home appliances and the increasing consumer demand for smart, fashionable, and personalized products[104]. - The automotive materials sector is focusing on lightweight solutions, with a 10% reduction in vehicle weight potentially improving fuel efficiency by 6%-8%[105]. Research and Development - Research and development expenses increased by 45.72% to ¥20.45 million, compared to ¥14.03 million in 2022[62]. - The company holds a total of 26 patents, an increase from 22 in the previous period, including 21 invention patents, up from 17[88]. - The company is in the pilot stage for several R&D projects, including a high-performance material for automotive applications, aiming for tensile strength of ≥90MPa and impact strength of ≥80KJ/m²[90]. - The company is focusing on technological innovation to meet customized product demands, particularly in import substitution products[64]. - The overall R&D strategy includes a focus on high-performance materials for automotive and medical applications, indicating a targeted market expansion approach[90]. Financial Position and Liabilities - The company's cash and cash equivalents at the end of 2023 amounted to 90.22 million, an increase of 234.17% compared to the end of 2022, primarily due to the net proceeds of 126.20 million from the public offering of shares on September 18, 2023[51]. - Accounts receivable increased to 307.20 million, representing a growth of 6.49% year-over-year, indicating a stable demand for the company's products[51]. - Prepayments rose significantly to 55.53 million, a 350.14% increase, mainly due to advance payments for raw materials from suppliers[51]. - Inventory at the end of 2023 reached 127.13 million, up 206.05% from the previous year, driven by increased orders and a strategic decision to build safety stock[52]. - Short-term borrowings increased to 126.50 million, reflecting a 138.97% rise, attributed to multiple short-term loans taken throughout the year[53]. - The total amount of contract liabilities decreased by 41.66% to 2.55 million, as previously received payments were recognized as revenue during the reporting period[54]. Legal and Compliance - The company is involved in a legal dispute with Guangzhou Lefeng Medical Equipment Co., with a claimed amount of ¥1,981,200, representing 0.43% of net assets[119]. - The company has a pending case against Xiamen Jiuyi Industrial Co., with a claimed amount of ¥3,053,296, which is 0.67% of net assets[120]. - The company has received a civil judgment in a case against Guangzhou Lefeng, with further appeals ongoing[122]. - The company filed an appeal on November 9, 2023, against the judgment from the Bao'an District People's Court[123]. Governance and Management - The management team consists of 5 directors, 3 supervisors, and 4 senior executives, with total compensation for key personnel ranging from 1.00 million to 65.41 million[160]. - The company has established a new corporate governance system during the year[177]. - The company has implemented a labor contract system for all employees, ensuring compliance with labor laws[170]. - The company has maintained a consistent approach to protecting the rights of minority shareholders in its dividend distribution process[157]. - The governance structure has been designed to uphold the rights of shareholders, allowing them to exercise their rights to information, participation, inquiry, and voting[179]. Financing Activities - The company secured a bank loan of $30 million from Ningbo with a guarantee provided by Yao Xiuzhu and Zheng, set to mature in October 2025[129]. - A loan of $50 million was obtained from Everbright, guaranteed by Yao Xiuzhu and Zheng, maturing in November 2024[129]. - The company has multiple loans with varying amounts and interest rates, indicating a diverse financing strategy[154]. - The total loan amount reported is approximately 554.37 million, with various banks contributing different amounts and interest rates ranging from 3.75% to 5.55%[155]. Shareholder Information - The largest shareholder, Yao Xiuzhu, holds 38,459,321 shares, representing 35.47% of the total shares, while the top ten shareholders collectively hold 65.69%[140]. - The number of common stock shareholders increased to 5,528 following the public offering[138]. - The company approved a cash dividend distribution plan of 1.5 yuan per 10 shares, with no stock bonus or capital increase proposed[158]. Future Outlook - The company plans to expand its global market presence and product line while enhancing its R&D capabilities[107]. - The company is affected by macroeconomic cycles and international trade uncertainties, which may impact its downstream industries[108]. - The company will focus on its core technologies and product applications to enhance its risk resistance and ensure stable development[109].
富恒新材:第四届监事会第十六次会议决议公告
2024-04-26 14:14
第四届监事会第十六次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 本次会议召集、召开符合《公司法》及《公司章程》的规定,会议决议合法有效。 (二)会议出席情况 会议应出席监事 3 人,出席和授权出席监事 3 人。 证券代码:832469 证券简称:富恒新材 公告编号:2024-021 深圳市富恒新材料股份有限公司 二、议案审议情况 (一)审议通过《关于<2023 年度监事会工作报告>的议案》 1.议案内容: 2023年度,公司监事会按照《公司法》和《公司章程》的规定,本着对全体 股东负责的精神,认真履行监督职能。报告期内,共召开9次监事会会议,列席 了董事会与股东大会,对公司重大的经济活动、董事和高级管理人员履行职责进 (一)会议召开情况 1.会议召开时间:2024 年 4 月 26 日 2.会议召开地点:公司会议室 3.会议召开方式:现场 4.发出监事会会议通知的时间和方式:2024 年 4 月 16 日以邮件方式发出 5.会议主持人:刘明先生 6.召开情况合法 ...
富恒新材:董事会关于2023年度独立董事独立性自查情况的专项报告
2024-04-26 14:14
证券代码:832469 证券简称:富恒新材 公告编号:2024-030 深圳市富恒新材料股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 根据中国证券监督管理委员会《上市公司独立董事管理办法》等相关规定, 深圳市富恒新材料股份有限公司(以下简称"公司")董事会就公司在任独立董 事高香林、刘勇的独立性情况进行评估并出具了专项意见。 (六)独立董事不是为公司及公司控股股东、实际控制人或者其各自附属企 董事会关于 2023 年度独立董事独立性自查情况的专项报告 根据独立董事向董事会提供的关于独立性情况的自查报告,结合其他相关资 料,董事会就独立董事的独立性形成如下结论: (一)独立董事及其配偶、父母、子女、具有主要社会关系的人员未在公司 或公司附属企业任职; (二)独立董事及其配偶、父母、子女未直接或间接持有公司已发行股份百 分之一以上,不是公司前十名股东中的自然人股东; (三)独立董事及其配偶、父母、子女不是直接或间接持有公司已发行股份 百分之五以上的股东,未在公司前五名股东任职; (四)独立董 ...
富恒新材:关联担保公告
2024-04-26 14:14
证券代码:832469 证券简称:富恒新材 公告编号:2024-036 深圳市富恒新材料股份有限公司 关联担保公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、关联交易概述 (一)关联交易概述 公司因业务发展需要,拟向深圳农村商业银行股份有限公司龙岗支行申请人 民币 10,000 万元的综合授信额度,额度期限为 3 年。用途为归还借款及流动资 金周转。具体内容以双方实际签订的借款合同为准。 公司因业务发展需要,拟向交通银行股份有限公司深圳分行申请金额为人民 币 5,000 万元的贷款,贷款期限为 2 年,用于日常资金周转。具体内容以双方实 际签订的借款合同为准。 公司因业务发展需要,拟向中信银行股份有限公司深圳分行申请金额为人民 币 5,000 万元的综合授信额度,期限为 2 年,用于采购原材料等日常资金周转。 具体内容以双方实际签订的合同为准。 公司因业务发展需要,拟向恒丰银行股份有限公司深圳分行申请金额为人民 币 6,000 万元的贷款,额度有效期为 12 个月,用于支付上游货款、补充流动资 ...
富恒新材:2023年度独立董事述职报告(刘勇)
2024-04-26 14:14
证券代码:832469 证券简称:富恒新材 公告编号:2024-017 深圳市富恒新材料股份有限公司 2023 年度独立董事述职报告(刘勇) 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人作为深圳市富恒新材料股份有限公司(以下简称"公司")的独立董事, 能够严格按照《中华人民共和国公司法》《北京证券交易所股票上市规则(试行)》 《北京证券交易所上市公司持续监管指引第 1 号——独立董事》等有关法律、法 规及《深圳市富恒新材料股份有限公司章程》《深圳市富恒新材料股份有限公司独 立董事工作制度》的相关规定和要求,忠实、勤勉、尽责地履行相关职责和义务, 积极出席相关会议,及时了解公司的生产经营信息,关注公司的发展状况,认真 审议董事会各项议案,并针对相关议案发表独立性意见,充分发挥独立董事的独 立性和专业性作用,切实维护了公司和股东尤其是中小股东的利益。现将本人在 2023 年度履行职责的情况汇报如下: 一、独立董事的基本情况 刘勇,男,1970 年 3 月出生,中国江西抚州人,无境外永久居留权,硕士, ...
富恒新材(832469) - 2024 Q1 - 季度财报
2024-04-26 14:14
Financial Performance - Net profit attributable to shareholders for Q1 2024 was ¥19,162,345.53, representing a 112.29% increase year-over-year[12] - Operating revenue for Q1 2024 was ¥173,807,246.13, up 50.44% from ¥115,534,277.73 in the same period last year[12] - The company's operating profit for Q1 2024 was ¥13,921,224.11, an increase from ¥9,816,173.18 in Q1 2023[39] - Total revenue for Q1 2024 reached ¥173,807,246.13, a significant increase from ¥115,534,277.73 in Q1 2023, representing a growth of approximately 50.4%[36] - Net profit increased by CNY 10.1084 million, up 112.53%, driven by higher operating revenue and increased government subsidies[15] - The total profit for Q1 2024 was ¥13,924,126.26, an increase from ¥9,794,315.23 in Q1 2023[39] - Basic and diluted earnings per share for Q1 2024 were both ¥0.18, compared to ¥0.11 in Q1 2023[38] - The total comprehensive income for Q1 2024 was ¥11,898,794.71, compared to ¥8,305,550.46 in Q1 2023[40] Assets and Liabilities - Total assets as of March 31, 2024, reached ¥1,021,513,217.64, an increase of 2.86% compared to the end of 2023[12] - Current assets totaled CNY 676,752,922.03, up from CNY 656,012,050.12, indicating an increase of about 3.0%[30] - Total liabilities amounted to CNY 543,982,527.54, slightly up from CNY 536,162,949.69, showing an increase of about 1.5%[32] - Total liabilities increased to ¥382,084,133.81 as of March 31, 2024, from ¥369,683,476.68 at the end of 2023, reflecting a growth of about 3.6%[35] - The company's equity attributable to shareholders rose to CNY 477,530,690.10 from CNY 458,438,990.29, an increase of approximately 4.2%[32] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥59,382,559.47, a decline of 131.86% compared to the previous year[12] - Cash flow from operating activities decreased by CNY 33.7710 million, a decline of 131.86%, due to reduced cash received from sales[15] - Cash inflow from operating activities was 271,032,795.04, a decrease from 353,882,414.44 in the previous year[44] - The net cash flow from operating activities was -59,345,370.27, reflecting a decline in operational performance compared to the previous year[45] - Cash inflow from financing activities totaled 85,881,898.70, with a net cash flow of 47,749,452.80, showing a strong financing position[43] Investments and Expenses - R&D expenses increased by CNY 1.9808 million, accounting for 43.16% of total expenses, due to enhanced investment in product technology innovation[15] - Research and development expenses rose to ¥6,570,001.28 in Q1 2024, compared to ¥4,589,158.25 in Q1 2023, reflecting a growth of approximately 43.2%[36] - Investment income surged by CNY 4.1130 million, a 2,512.02% increase, mainly from the sale of equity in a subsidiary[15] - Total operating costs for Q1 2024 were ¥160,714,335.07, up from ¥104,335,261.11 in Q1 2023, indicating an increase of about 54%[36] Shareholder Information - The total number of ordinary shares is 108,420,000, with 3,322 shareholders[19] - Major shareholders include Yao Xiuzhu with 35.47% and Shenzhen Tolu Equity Investment Partnership with 5.03%[20] Other Significant Events - The company completed the sale of its controlling subsidiary, 富恒精密, and no longer consolidates it in its financial statements[26] - A civil mediation agreement was reached regarding a contract dispute with 深圳铭锋达科技有限公司, allowing for installment payments[25] - The company has entered into a loan agreement with several banks, with related party guarantees provided by certain individuals[25]
富恒新材:2023年度独立董事述职报告(高香林)
2024-04-26 14:14
深圳市富恒新材料股份有限公司 证券代码:832469 证券简称:富恒新材 公告编号:2024-019 2023 年度独立董事述职报告(高香林) 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人作为深圳市富恒新材料股份有限公司(以下简称"公司")的独立董事, 能够严格按照《中华人民共和国公司法》《北京证券交易所股票上市规则(试行)》 《北京证券交易所上市公司持续监管指引第 1 号——独立董事》等有关法律、法 规及《深圳市富恒新材料股份有限公司章程》《深圳市富恒新材料股份有限公司独 立董事工作制度》的相关规定和要求,忠实、勤勉、尽责地履行相关职责和义务, 积极出席相关会议,及时了解公司的生产经营信息,关注公司的发展状况,认真 审议董事会各项议案,并针对相关议案发表独立性意见,充分发挥独立董事的独 立性和专业性作用,切实维护了公司和股东尤其是中小股东的利益。现将本人在 2023 年度履行职责的情况汇报如下: 一、独立董事的基本情况 高香林:男,1965 年出生,中国国籍,无境外永久居留权,研究生学历,会 ...